Respiratory Panel

Description: 
Qualitative molecular respiratory panel assay for the detection of nuceic acid from both viral and bacterial targets by multiplex tandem PCR, including specific SARS-CoV-2 gene sequences Orf1a & Orf8. This assay will detect Influenza A (including H1 typing, and H3 typing), Influenza B, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Seasonal Coronavirus, Respiratory Syncytial Virus (RSV), Parainfluenza including typing, human Parechovirus, Enterovirus, Rhinovirus, human Metapneumovirus, Adenovirus, Bordetella (B. pertussis, B. holmesii, B. bronchiseptica, B. parapertussis), Legionella (L. pneumophila, L. longbeachae), Chlamydophila pneumoniae, Chlamydophila psittaci, Pneumocystis jiroveci and Mycoplasma pneumoniae.
Clinical details: 
Respiratory tract infections can be caused by a wide range of pathogens which are rarely clinically distinguishable. Correct and early identification has important treatment and infection control implications. Further comprehensive information is available in specific GSTT Infection control guidelines via the GTi website or by contacting the virology SpR on x83140 or Duty Consultant via the switchboard.
Reference range: 

Not Applicable

Synonyms or keywords: 
Influenza, flu', COVID-19, bronchiolitis, coryza, Mycoplasma, Legionnaires, PCP, Pertussis, whooping cough, infection control
Units: 
Qualitative Test - Detected/Not Detected

Print as a PDF

Last updated: 06/10/2023